Medsquare has been selected by the Gustave Roussy Cancer Centre, which has chosen to be equipped by Medsquare’s Patient Dose Monitoring solution Radiation Dose Monitor (RDM). For this DACS acquisition project, signed via the French Purchasing group ’Resah’, Gustave Roussy has indicated that it wants to replace its existing DACS solution, notably expressing the need to recover and exploit data from its previous DACS.
Arnaud Legland, Medsquare’s Channel Sales Manager Europe, says: “We are delighted that Gustave Roussy has entrusted Medsquare with its project for the complete renewal and deployment of DACS. Collaborating with the premier European Cancer Centre is an honor for the Medsquare team. Moreover, replacing an existing DACS is a mission that we have already successfully completed, particularly at several levels (regional, hospitals and university hospitals).”
By becoming Gustave Roussy’s preferred partner, Medsquare is committed to being a key player in the Centre’s Patient Dose Management project, with the following objectives:
– Adapt the DACS RDM solution to the issues of Europe’s premier Cancer Centre in the fight against cancer,
– Promote and value Gustave Roussy’s most innovative actions in patient dose monitoring,
– Provide Gustave Roussy with dedicated support throughout the use of the DACS RDM.
With RDM, patient dose data can be consolidated and used anonymously for research purposes. The goal is to share and use monitoring data (dose history) for clinical research at any time.
In addition, Gustave Roussy could be at the heart of a regional DACS in the Ile-de-France region as well as other establishments that also benefit from this regional dosimetry service. A deployment is currently underway at the Bordeaux University Hospital (the Krypton project in partnership with Carestream), which will soon benefit from this patient dose service in the French New Aquitaine region.
“The DACS project at Gustave Roussy is part of an initiative to raise the awareness of healthcare professionals about patient radiation protection, an approach that has been at the heart of Medsquare’s activity since 2010,” confirms Arnaud Legland. “With RDM, patient radiation protection professionals will be able to rely on powerful dose assessment tools that offer them the ability to control dose delivered to patients, facilitate data analysis, and remain alert to patient safety and thus improve the quality of care,” he adds.